Showing results (121-130 of 5,438) with videos related to
Sort By:
Pageof 544
Cancer Research|July 1, 1985
Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell linesA Fojo, S Akiyama, M M Gottesman, et al.Molecular and Cellular Biology|May 1, 1986
Transfer and amplification of a mutant beta-tubulin gene results in colcemid dependence: use of the transformant to demonstrate regulation of beta-tubulin subunit levels by protein degradationC Whitfield, I Abraham, D Ascherman, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1979
Hyperdegradation of proteins in Escherichia coli rho mutantsL D Simon, M Gottesman, K Tomczak, et al.Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
New mechanisms of multidrug resistance: an introduction to the Cancer Drug Resistance special collectionMichael M Gottesman, Robert W Robey, Suresh V AmbudkarMolecular Pharmacology|April 23, 2004
Down-regulation and altered localization of gamma-catenin in cisplatin-resistant adenocarcinoma cellsXing-Jie Liang, Ding-Wu Shen, Michael M GottesmanJournal of Bacteriology|January 1, 1986
Translation initiation of bacteriophage lambda gene cII requires integration host factorJ Mahajna, A B Oppenheim, A Rattray, et al.Discovery Medicine|January 20, 2007
Defeating drug resistance in cancerMichael M Gottesman, Joseph Ludwig, Di Xia, et al.Biochimica Et Biophysica Acta|January 9, 1991
Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesiclesM Horio, E Lovelace, I Pastan, et al.Bulletin of Mathematical Biology|February 21, 2014
The impact of cell density and mutations in a model of multidrug resistance in solid tumorsJames Greene, Orit Lavi, Michael M Gottesman, et al.Stem Cells (Dayton, Ohio)|January 1, 1997
In vivo drug-selectable genes: a new concept in gene therapyT Licht, F Herrmann, M M Gottesman, et al.Pageof 544